[HTML][HTML] Small intestinal bacterial overgrowth: clinical features and therapeutic management

SSC Rao, J Bhagatwala - Clinical and translational …, 2019 - journals.lww.com
Small intestinal bacterial overgrowth (SIBO) is a common, yet underrecognized, problem. Its
prevalence is unknown because SIBO requires diagnostic testing. Although abdominal …

[HTML][HTML] Gastrointestinal dysfunction in Parkinson's disease: current and potential therapeutics

MN Han, DI Finkelstein, RM McQuade… - Journal of Personalized …, 2022 - mdpi.com
Abnormalities in the gastrointestinal (GI) tract of Parkinson's disease (PD) sufferers were first
reported over 200 years ago; however, the extent and role of GI dysfunction in PD disease …

Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging

GT Dempsey, KW Chaudhary, N Atwater… - … of pharmacological and …, 2016 - Elsevier
Abstract Introduction The Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative
seeks an in vitro test to accurately predict clinical Torsades de Pointes (TdP). We developed …

[HTML][HTML] A deep learning platform to assess drug proarrhythmia risk

R Serrano, DAM Feyen, AAN Bruyneel, AP Hnatiuk… - Cell Stem Cell, 2023 - cell.com
Drug safety initiatives have endorsed human iPSC-derived cardiomyocytes (hiPSC-CMs) as
an in vitro model for predicting drug-induced cardiac arrhythmia. However, the extent to …

[HTML][HTML] Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect-comprehensive overview of clinical trials

B Wiśniowska, Z Tylutki, G Wyszogrodzka… - BMC Pharmacology and …, 2016 - Springer
Background Proarrhythmia assessment is one of the major concerns for regulatory bodies
and pharmaceutical industry. ICH guidelines recommending preclinical tests have been …

Validation of diagnostic codes for outpatient‐originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data

S Hennessy, CE Leonard, CP Freeman… - … and drug safety, 2010 - Wiley Online Library
Purpose Sudden cardiac death (SD) and ventricular arrhythmias (VAs) caused by
medications have arisen as an important public health concern in recent years. The validity …

[HTML][HTML] Gastrointestinal involvement in systemic sclerosis: an update

JB Miller, N Gandhi, J Clarke… - JCR: Journal of Clinical …, 2018 - journals.lww.com
Systemic sclerosis is an autoimmune disease characterized by vasculopathy, progressive
fibrosis of the skin, and internal organ dysfunction. Gastrointestinal (GI) disease is the most …

Gastroparesis: approach, diagnostic evaluation, and management

DM Tang, FK Friedenberg - Disease-a-Month, 2011 - Elsevier
Gastroparesis is a chronic motility disorder of the stomach that involves delayed emptying of
solids and liquids, without evidence of mechanical obstruction. Although no cause can be …

[HTML][HTML] Recent advances in understanding and managing chronic constipation

DO Prichard, AE Bharucha - F1000Research, 2018 - ncbi.nlm.nih.gov
Constipation, a condition characterized by heterogeneous symptoms, is common in Western
society. It is associated with reduced physical health, mental health, and social functioning …

Update on pediatric gastroparesis: a review of the published literature and recommendations for future research

K Kovacic, W Elfar, JM Rosen, D Yacob… - …, 2020 - Wiley Online Library
Background Due to scarcity of scientific literature on pediatric gastroparesis, there is a need
to summarize current evidence and identify areas requiring further research. The aim of this …